Ventricular Arrhythmias in Patients With a Continuous-Flow Left Ventricular Assist Device

Continuous-flow left ventricular assist devices (CF-LVADs) are increasingly used in the management of patients with end-stage heart failure; however, CF-LVAD support can be hampered by the occurrence of ventricular arrhythmias (VAs) (1-5). In a multivariate Cox regression model, only pre-LVAD VA rem...

Full description

Saved in:
Bibliographic Details
Published inJournal of the American College of Cardiology Vol. 68; no. 3; pp. 323 - 325
Main Authors Yap, Sing-Chien, MD, PhD, Ramjankhan, Faiz, MD, Muslem, Rahat, de Jonge, Nicolaas, MD, PhD, Kirkels, Hans J., MD, PhD, Akin, Sakir, MD, Manintveld, Olivier C., MD, PhD, Birim, Ozcan, MD, PhD, Szili-Torok, Tamas, MD, PhD, Caliskan, Kadir, MD, PhD
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 19.07.2016
Elsevier Limited
Subjects
Cardiology
Cardiovascular
Clinical outcomes
Confidence intervals
Internal Medicine
Mortality
Online AccessGet full text

Cover

More Information
Summary:Continuous-flow left ventricular assist devices (CF-LVADs) are increasingly used in the management of patients with end-stage heart failure; however, CF-LVAD support can be hampered by the occurrence of ventricular arrhythmias (VAs) (1-5). In a multivariate Cox regression model, only pre-LVAD VA remained as an independent predictor of late post-LVAD VA (adjusted hazard ratio [HR]: 2.13; 95% confidence interval [CI]: 1.06 to 4.27; p = 0.03) (Figure 1B).
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0735-1097
1558-3597
DOI:10.1016/j.jacc.2016.05.016